Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Shares Issued (2016 - 2026)

Bio-Techne has reported Shares Issued over the past 17 years, most recently at $4.7 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 14.46% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $49.3 million, down 31.39%, while the annual FY2025 figure was $51.7 million, 15.09% down from the prior year.
  • Shares Issued for Q4 2025 was $4.7 million at Bio-Techne, down from $23.5 million in the prior quarter.
  • Over five years, Shares Issued peaked at $37.9 million in Q3 2021 and troughed at $4.4 million in Q1 2023.
  • A 5-year average of $14.0 million and a median of $11.9 million in 2022 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: crashed 73.0% in 2022 and later skyrocketed 314.54% in 2024.
  • Year by year, Shares Issued stood at $18.6 million in 2021, then crashed by 73.0% to $5.0 million in 2022, then increased by 4.95% to $5.3 million in 2023, then rose by 5.0% to $5.5 million in 2024, then decreased by 14.46% to $4.7 million in 2025.
  • Business Quant data shows Shares Issued for TECH at $4.7 million in Q4 2025, $23.5 million in Q3 2025, and $6.2 million in Q2 2025.